<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38953667</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Identification of the proteolytic signature in CVB3-infected cells.</ArticleTitle><Pagination><StartPage>e0049824</StartPage><MedlinePgn>e0049824</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00498-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00498-24</ELocationID><Abstract><AbstractText Label="UNLABELLED">Coxsackievirus B3 (CVB3) encodes proteinases that are essential for processing of the translated viral polyprotein. Viral proteinases also target host proteins to manipulate cellular processes and evade innate antiviral responses to promote replication and infection. While some host protein substrates of the CVB3 3C and 2A cysteine proteinases have been identified, the full repertoire of targets is not known. Here, we utilize an unbiased quantitative proteomics-based approach termed terminal amine isotopic labeling of substrates (TAILS) to conduct a global analysis of CVB3 protease-generated N-terminal peptides in both human HeLa and mouse cardiomyocyte (HL-1) cell lines infected with CVB3. We identified &gt;800 proteins that are cleaved in CVB3-infected HeLa and HL-1 cells including the viral polyprotein, known substrates of viral 3C proteinase such as PABP, DDX58, and HNRNPs M, K, and D and novel cellular proteins. Network and GO-term analysis showed an enrichment in biological processes including immune response and activation, RNA processing, and lipid metabolism. We validated a subset of candidate substrates that are cleaved under CVB3 infection and some are direct targets of 3C proteinase <i>in vitro</i>. Moreover, depletion of a subset of TAILS-identified target proteins decreased viral yield. Characterization of two target proteins showed that expression of 3C<sup>pro</sup>-targeted cleaved fragments of emerin and aminoacyl-tRNA synthetase complex-interacting multifunctional protein 2 modulated autophagy and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, respectively. The comprehensive identification of host proteins targeted during virus infection provides insights into the cellular pathways manipulated to facilitate infection.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">RNA viruses encode proteases that are responsible for processing viral proteins into their mature form. Viral proteases also target and cleave host cellular proteins; however, the full catalog of these target proteins is incomplete. We use a technique called terminal amine isotopic labeling of substrates (TAILS), an N-terminomics to identify host proteins that are cleaved under virus infection. We identify hundreds of cellular proteins that are cleaved under infection, some of which are targeted directly by viral protease. Revealing these target proteins provides insights into the host cellular pathways and antiviral signaling factors that are modulated to promote virus infection and potentially leading to virus-induced pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vlok</LastName><ForeName>Marli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solis</LastName><ForeName>Nestor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Oral and Biological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadasivan</LastName><ForeName>Jibin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamud</LastName><ForeName>Yasir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warsaba</LastName><ForeName>Reid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kizhakkedathu</LastName><ForeName>Jayachandran</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7688-7574</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7708-7840</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart and Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overall</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-5844-2731</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral and Biological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yonsei Frontier Lab, Yonsei University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jan</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0523-8467</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PJT-156351, PJT-173318, FDN-148408</GrantID><Agency>Canadian Government | Canadian Institutes of Health Research (CIHR)</Agency><Country /></Grant><Grant><GrantID>RGPIN-2017-04515, RGPIN-2022-02979, PGS D</GrantID><Agency>Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)</Agency><Country /></Grant><Grant><Agency>DST | Science and Engineering Research Board (SERB)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D000085242">Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020815">Polyproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="Y">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085242" MajorTopicYN="N">Viral Proteases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020815" MajorTopicYN="N">Polyproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIMP2</Keyword><Keyword MajorTopicYN="N">EMD</Keyword><Keyword MajorTopicYN="N">N-terminomics</Keyword><Keyword MajorTopicYN="N">degradomics</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">protease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>14</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38953667</ArticleId><ArticleId IdType="pmc">PMC11265341</ArticleId><ArticleId IdType="doi">10.1128/jvi.00498-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olejniczak M, Schwartz M, Webber E, Shaffer A, Perry TE. 2020. Viral myocarditis-incidence diagnosis and management. J Cardiothorac Vasc Anesth 34:1591–1601. doi:10.1053/j.jvca.2019.12.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.12.052</ArticleId><ArticleId IdType="pubmed">32127272</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators GBoDS . 2015. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 386:743–800. doi:10.1016/S0140-6736(15)60692-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60692-4</ArticleId><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>Buggey J, ElAmm CA. 2018. Myocarditis and cardiomyopathy. Curr Opin Cardiol 33:341–346. doi:10.1097/HCO.0000000000000514</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000514</ArticleId><ArticleId IdType="pubmed">29528905</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, McManus BM. 2008. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127–155. doi:10.1146/annurev.pathmechdis.3.121806.151534</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G, Luo H, Qiu Y, Yang D, McManus B. 2016. Myocarditis. Circ Res 118:496–514. doi:10.1161/CIRCRESAHA.115.306573</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306573</ArticleId><ArticleId IdType="pubmed">26846643</ArticleId></ArticleIdList></Reference><Reference><Citation>Baboonian C, Treasure T. 1997. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539–543. doi:10.1136/hrt.78.6.539</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.78.6.539</ArticleId><ArticleId IdType="pmc">PMC1892342</ArticleId><ArticleId IdType="pubmed">9470867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. 2005. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111:887–893. doi:10.1161/01.CIR.0000155616.07901.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000155616.07901.35</ArticleId><ArticleId IdType="pubmed">15699250</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L, Moreni G, Wolthers KC, Pajkrt D. 2021. World-wide prevalence and genotype distribution of enteroviruses. Viruses 13:434. doi:10.3390/v13030434</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030434</ArticleId><ArticleId IdType="pmc">PMC7999254</ArticleId><ArticleId IdType="pubmed">33800518</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M-L, Shih S-R, Tolbert BS, Brewer G. 2021. Enterovirus A71 vaccines. Vaccines (Basel) 9:199. doi:10.3390/vaccines9030199</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030199</ArticleId><ArticleId IdType="pmc">PMC7997495</ArticleId><ArticleId IdType="pubmed">33673595</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg AC. 1990. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol 44:603–623. doi:10.1146/annurev.mi.44.100190.003131</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.44.100190.003131</ArticleId><ArticleId IdType="pubmed">2252396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlotnick A, Reddy VS, Dasgupta R, Schneemann A, Ray WJ, Rueckert RR, Johnson JE. 1994. Capsid assembly in a family of animal viruses primes an autoproteolytic maturation that depends on a single aspartic acid residue. J Biol Chem 269:13680–13684. doi:10.1016/S0021-9258(17)36883-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)36883-7</ArticleId><ArticleId IdType="pubmed">8175803</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold E, Luo M, Vriend G, Rossmann MG, Palmenberg AC, Parks GD, Nicklin MJ, Wimmer E. 1987. Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci USA 84:21–25. doi:10.1073/pnas.84.1.21</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.1.21</ArticleId><ArticleId IdType="pmc">PMC304133</ArticleId><ArticleId IdType="pubmed">3467351</ArticleId></ArticleIdList></Reference><Reference><Citation>Seipelt J, Guarné A, Bergmann E, James M, Sommergruber W, Fita I, Skern T. 1999. The structures of picornaviral proteinases. Virus Res 62:159–168. doi:10.1016/s0168-1702(99)00043-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0168-1702(99)00043-x</ArticleId><ArticleId IdType="pubmed">10507325</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosimann SC, Cherney MM, Sia S, Plotch S, James MN. 1997. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J Mol Biol 273:1032–1047. doi:10.1006/jmbi.1997.1306</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1997.1306</ArticleId><ArticleId IdType="pubmed">9367789</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Svedin E, Kapell S, Nurminen A, Hytönen VP, Flodström-Tullberg M. 2016. Enteroviral proteases: structure, host interactions and pathogenicity. Rev Med Virol 26:251–267. doi:10.1002/rmv.1883</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbalenya AE, Donchenko AP, Blinov VM, Koonin EV. 1989. Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases. A distinct protein superfamily with a common structural fold. FEBS Lett 243:103–114. doi:10.1016/0014-5793(89)80109-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(89)80109-7</ArticleId><ArticleId IdType="pubmed">2645167</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom N, Hansen J, Blaas D, Brunak S. 1996. Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci 5:2203–2216. doi:10.1002/pro.5560051107</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560051107</ArticleId><ArticleId IdType="pmc">PMC2143287</ArticleId><ArticleId IdType="pubmed">8931139</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H, Nicklin MJ, Murray MG, Anderson CW, Dunn JJ, Studier FW, Wimmer E. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761–770. doi:10.1016/0092-8674(86)90790-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90790-7</ArticleId><ArticleId IdType="pubmed">3011278</ArticleId></ArticleIdList></Reference><Reference><Citation>Flather D, Semler BL. 2015. Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front Microbiol 6:594. doi:10.3389/fmicb.2015.00594</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2015.00594</ArticleId><ArticleId IdType="pmc">PMC4471892</ArticleId><ArticleId IdType="pubmed">26150805</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebig HD, Ziegler E, Yan R, Hartmuth K, Klump H, Kowalski H, Blaas D, Sommergruber W, Frasel L, Lamphear B. 1993. Purification of two picornaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation. Biochemistry 32:7581–7588. doi:10.1021/bi00080a033</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00080a033</ArticleId><ArticleId IdType="pubmed">8338854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamphear BJ, Yan R, Yang F, Waters D, Liebig HD, Klump H, Kuechler E, Skern T, Rhoads RE. 1993. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human coxsackievirus and rhinovirus. J Biol Chem 268:19200–19203.</Citation><ArticleIdList><ArticleId IdType="pubmed">8396129</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. 1982. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257:14806–14810.</Citation><ArticleIdList><ArticleId IdType="pubmed">6294080</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171–176. doi:10.1016/j.virol.2009.06.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.06.045</ArticleId><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311. doi:10.1371/journal.ppat.1001311</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJM. 2014. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88:3369–3378. doi:10.1128/JVI.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Zhang J, Yanagawa B, Luo Z, Yang X, Chang J, McManus B, Luo H. 2012. Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function. Cell Res 22:360–371. doi:10.1038/cr.2011.114</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.114</ArticleId><ArticleId IdType="pmc">PMC3271589</ArticleId><ArticleId IdType="pubmed">21769134</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Wong J, Fung G, Shi J, Deng H, Zhang J, Bernatchez P, Luo H. 2015. Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy. Cell Microbiol 17:1423–1430. doi:10.1111/cmi.12473</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12473</ArticleId><ArticleId IdType="pubmed">26073173</ArticleId></ArticleIdList></Reference><Reference><Citation>Badorff C, Berkely N, Mehrotra S, Talhouk JW, Rhoads RE, Knowlton KU. 2000. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 275:11191–11197. doi:10.1074/jbc.275.15.11191</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.15.11191</ArticleId><ArticleId IdType="pubmed">10753926</ArticleId></ArticleIdList></Reference><Reference><Citation>Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. 1999. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326. doi:10.1038/6543</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/6543</ArticleId><ArticleId IdType="pubmed">10086389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson PJ, Hossain AR, Qiu Y, Zhang HM, Zhao G, Li C, Lin V, Sulaimon S, Vlok M, Fung G, Chen VH, Jan E, McManus BM, Granville DJ, Yang D. 2019. Cleavage and sub-cellular redistribution of nuclear pore protein 98 by coxsackievirus B3 protease 2A impairs cardioprotection. Front Cell Infect Microbiol 9:265. doi:10.3389/fcimb.2019.00265</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00265</ArticleId><ArticleId IdType="pmc">PMC6667557</ArticleId><ArticleId IdType="pubmed">31396490</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, Kapell S, Hertz NT, Wu X, Bell K, Ashbrook AW, Mark MT, Zebroski HA, Neal ML, Flodström-Tullberg M, MacDonald MR, Aitchison JD, Molina H, Rice CM. 2020. Defining the proteolytic landscape during enterovirus infection. PLoS Pathog 16:e1008927. doi:10.1371/journal.ppat.1008927</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008927</ArticleId><ArticleId IdType="pmc">PMC7549765</ArticleId><ArticleId IdType="pubmed">32997711</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagdeo JM, Dufour A, Klein T, Solis N, Kleifeld O, Kizhakkedathu J, Luo H, Overall CM, Jan E. 2018. N-Terminomics TAILS identifies host cell substrates of poliovirus and coxsackievirus B3 3C proteinases that modulate virus infection. J Virol 92:e02211-17. doi:10.1128/JVI.02211-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02211-17</ArticleId><ArticleId IdType="pmc">PMC5874412</ArticleId><ArticleId IdType="pubmed">29437971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill ME, Kumar A, Wells JA, Hobman TC, Julien O, Hardy JA. 2018. The unique cofactor region of Zika virus NS2B-NS3 protease facilitates cleavage of key host proteins. ACS Chem Biol 13:2398–2405. doi:10.1021/acschembio.8b00508</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00508</ArticleId><ArticleId IdType="pubmed">30080377</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, Grauslys A, Walter M, Agou F, Chakrabarti LA, Craik CS, Eyers CE, Eyers PA, Gambin Y, Jones AR, Sierecki E, Verdin E, Vignuzzi M, Emmott E. 2021. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential. Nat Commun 12:5553. doi:10.1038/s41467-021-25796-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25796-w</ArticleId><ArticleId IdType="pmc">PMC8455558</ArticleId><ArticleId IdType="pubmed">34548480</ArticleId></ArticleIdList></Reference><Reference><Citation>Pablos I, Machado Y, de Jesus HCR, Mohamud Y, Kappelhoff R, Lindskog C, Vlok M, Bell PA, Butler GS, Grin PM, et al. . 2021. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL. Cell Rep 37:109892. doi:10.1016/j.celrep.2021.109892</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109892</ArticleId><ArticleId IdType="pmc">PMC8501228</ArticleId><ArticleId IdType="pubmed">34672947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleifeld O, Doucet A, auf dem Keller U, Prudova A, Schilling O, Kainthan RK, Starr AE, Foster LJ, Kizhakkedathu JN, Overall CM. 2010. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 28:281–288. doi:10.1038/nbt.1611</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1611</ArticleId><ArticleId IdType="pubmed">20208520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleifeld O, Doucet A, Prudova A, auf dem Keller U, Gioia M, Kizhakkedathu JN, Overall CM. 2011. Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates. Nat Protoc 6:1578–1611. doi:10.1038/nprot.2011.382</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.382</ArticleId><ArticleId IdType="pubmed">21959240</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall NC, Klein T, Thejoe M, von Krosigk N, Kizhakkedathu J, Finlay BB, Overall CM. 2018. Global profiling of proteolysis from the mitochondrial amino terminome during early intrinsic apoptosis prior to Caspase-3 activation. J Proteome Res 17:4279–4296. doi:10.1021/acs.jproteome.8b00675</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00675</ArticleId><ArticleId IdType="pubmed">30371095</ArticleId></ArticleIdList></Reference><Reference><Citation>auf dem Keller U, Prudova A, Eckhard U, Fingleton B, Overall CM. 2013. Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation. Sci. Signal 6:rs2. doi:10.1126/scisignal.2003512</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2003512</ArticleId><ArticleId IdType="pmc">PMC3872078</ArticleId><ArticleId IdType="pubmed">23322905</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagdeo JM, Dufour A, Fung G, Luo H, Kleifeld O, Overall CM, Jan E. 2015. Heterogeneous nuclear ribonucleoprotein M facilitates enterovirus infection. J Virol 89:7064–7078. doi:10.1128/JVI.02977-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02977-14</ArticleId><ArticleId IdType="pmc">PMC4473559</ArticleId><ArticleId IdType="pubmed">25926642</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567. doi:10.1002/(SICI)1522-2683(19991201)20:18&lt;3551::AID-ELPS3551&gt;3.0.CO;2-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1522-2683(19991201)20:18&lt;3551::AID-ELPS3551&gt;3.0.CO;2-2</ArticleId><ArticleId IdType="pubmed">10612281</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ. 2010. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966–968. doi:10.1093/bioinformatics/btq054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq054</ArticleId><ArticleId IdType="pmc">PMC2844992</ArticleId><ArticleId IdType="pubmed">20147306</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino LK, Searle BC, Bollinger JG, Nunn B, MacLean B, MacCoss MJ. 2020. The Skyline ecosystem: informatics for quantitative mass spectrometry proteomics. Mass Spectrom Rev 39:229–244. doi:10.1002/mas.21540</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mas.21540</ArticleId><ArticleId IdType="pmc">PMC5799042</ArticleId><ArticleId IdType="pubmed">28691345</ArticleId></ArticleIdList></Reference><Reference><Citation>Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. 2015. InteractiVenn: a web-based tool for the analysis of SETS through Venn diagrams. BMC Bioinformatics 16:169. doi:10.1186/s12859-015-0611-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0611-3</ArticleId><ArticleId IdType="pmc">PMC4455604</ArticleId><ArticleId IdType="pubmed">25994840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortelny N, Yang S, Pavlidis P, Lange PF, Overall CM. 2015. Proteome TopFIND 3.0 with TopFINDer and pathfinder: database and analysis tools for the association of protein termini to pre- and post-translational events. Nucleic Acids Res 43:D290–7. doi:10.1093/nar/gku1012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1012</ArticleId><ArticleId IdType="pmc">PMC4383881</ArticleId><ArticleId IdType="pubmed">25332401</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizer ES, Thupari J, Han WF, Pinn ML, Chrest FJ, Frehywot GL, Townsend CA, Kuhajda FP. 2000. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 60:213–218.</Citation><ArticleIdList><ArticleId IdType="pubmed">10667561</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebscher S, Ambrose RL, Aktepe TE, Mikulasova A, Prier JE, Gillespie LK, Lopez-Denman AJ, Rupasinghe TWT, Tull D, McConville MJ, Mackenzie JM. 2018. Phospholipase A2 activity during the replication cycle of the flavivirus West Nile virus. PLoS Pathog 14:e1007029. doi:10.1371/journal.ppat.1007029</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007029</ArticleId><ArticleId IdType="pmc">PMC5945048</ArticleId><ArticleId IdType="pubmed">29709018</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep J, Ooi YS, Wilkinson AW, Peters CE, Foy E, Johnson JR, Zengel J, Ding S, Weng K-F, Laufman O, Jang G, Xu J, Young T, Verschueren E, Kobluk KJ, Elias JE, Sarnow P, Greenberg HB, Hüttenhain R, Nagamine CM, Andino R, Krogan NJ, Gozani O, Carette JE. 2019. Enterovirus pathogenesis requires the host methyltransferase SETD3. Nat Microbiol 4:2523–2537. doi:10.1038/s41564-019-0551-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0551-1</ArticleId><ArticleId IdType="pmc">PMC6879830</ArticleId><ArticleId IdType="pubmed">31527793</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, Bozym R, Morosky SA, Hanna SL, Mukherjee A, Tudor M, Kim KS, Cherry S. 2011. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9:70–82. doi:10.1016/j.chom.2011.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.01.001</ArticleId><ArticleId IdType="pmc">PMC3048761</ArticleId><ArticleId IdType="pubmed">21238948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KX, Phuektes P, Kumar P, Goh GYL, Moreau D, Chow VTK, Bard F, Chu JJH. 2016. Human genome-wide RNAi screen reveals host factors required for enterovirus 71 replication. Nat Commun 7:13150. doi:10.1038/ncomms13150</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13150</ArticleId><ArticleId IdType="pmc">PMC5071646</ArticleId><ArticleId IdType="pubmed">27748395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi YS, Majzoub K, Flynn RA, Mata MA, Diep J, Li JK, van Buuren N, Rumachik N, Johnson AG, Puschnik AS, Marceau CD, Mlera L, Grabowski JM, Kirkegaard K, Bloom ME, Sarnow P, Bertozzi CR, Carette JE. 2019. An RNA-centric dissection of host complexes controlling flavivirus infection. Nat Microbiol 4:2369–2382. doi:10.1038/s41564-019-0518-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0518-2</ArticleId><ArticleId IdType="pmc">PMC6879806</ArticleId><ArticleId IdType="pubmed">31384002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS, Lee K, Kim SJ, Cho S, Shin HJ, Kim C, Kim JS. 2018. Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection. Genome Res 28:859–868. doi:10.1101/gr.230250.117</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.230250.117</ArticleId><ArticleId IdType="pmc">PMC5991512</ArticleId><ArticleId IdType="pubmed">29712754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cathcart AL, Rozovics JM, Semler BL. 2013. Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections. J Virol 87:10423–10434. doi:10.1128/JVI.01049-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01049-13</ArticleId><ArticleId IdType="pmc">PMC3807403</ArticleId><ArticleId IdType="pubmed">23903828</ArticleId></ArticleIdList></Reference><Reference><Citation>Neznanov N, Chumakov KM, Neznanova L, Almasan A, Banerjee AK, Gudkov AV. 2005. Proteolytic cleavage of the P65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 280:24153–24158. doi:10.1074/jbc.M502303200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M502303200</ArticleId><ArticleId IdType="pubmed">15845545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind K, Svedin E, Domsgen E, Kapell S, Laitinen OH, Moll M, Flodström-Tullberg M. 2016. Coxsackievirus counters the host innate immune response by blocking type III interferon expression. J Gen Virol 97:1368–1380. doi:10.1099/jgv.0.000443</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000443</ArticleId><ArticleId IdType="pubmed">26935471</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA. 2016. Dynamic lipid landscape of picornavirus replication organelles. Curr Opin Virol 19:1–6. doi:10.1016/j.coviro.2016.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC9004531</ArticleId><ArticleId IdType="pubmed">27240115</ArticleId></ArticleIdList></Reference><Reference><Citation>Laufman O, Perrino J, Andino R. 2019. Viral generated inter-organelle contacts redirect lipid flux for genome replication. Cell 178:275–289. doi:10.1016/j.cell.2019.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.030</ArticleId><ArticleId IdType="pmc">PMC7077330</ArticleId><ArticleId IdType="pubmed">31204099</ArticleId></ArticleIdList></Reference><Reference><Citation>Nchoutmboube JA, Viktorova EG, Scott AJ, Ford LA, Pei Z, Watkins PA, Ernst RK, Belov GA. 2013. Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles. PLoS Pathog 9:e1003401. doi:10.1371/journal.ppat.1003401</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003401</ArticleId><ArticleId IdType="pmc">PMC3675155</ArticleId><ArticleId IdType="pubmed">23762027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassmann A, Henke A, Jarasch N, Lottspeich F, Saluz HP, Munder T. 2007. The human fatty acid synthase: a new therapeutic target for coxsackievirus B3-induced diseases. Antiviral Res 76:150–158. doi:10.1016/j.antiviral.2007.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2007.06.011</ArticleId><ArticleId IdType="pubmed">17662476</ArticleId></ArticleIdList></Reference><Reference><Citation>Berk JM, Tifft KE, Wilson KL. 2013. The nuclear envelope LEM-domain protein emerin. Nucleus 4:298–314. doi:10.4161/nucl.25751</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/nucl.25751</ArticleId><ArticleId IdType="pmc">PMC3810338</ArticleId><ArticleId IdType="pubmed">23873439</ArticleId></ArticleIdList></Reference><Reference><Citation>Deroyer C, Rénert AF, Merville MP, Fillet M. 2014. New role for EMD (emerin), a key inner nuclear membrane protein, as an enhancer of autophagosome formation in the C16-ceramide autophagy pathway. Autophagy 10:1229–1240. doi:10.4161/auto.28777</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.28777</ArticleId><ArticleId IdType="pmc">PMC4203549</ArticleId><ArticleId IdType="pubmed">24819607</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson WT. 2014. Poliovirus-induced changes in cellular membranes throughout infection. Curr Opin Virol 9:67–73. doi:10.1016/j.coviro.2014.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.09.007</ArticleId><ArticleId IdType="pmc">PMC4267968</ArticleId><ArticleId IdType="pubmed">25310497</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson WT, Giddings TH, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, Kirkegaard K. 2005. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 3:e156. doi:10.1371/journal.pbio.0030156</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0030156</ArticleId><ArticleId IdType="pmc">PMC1084330</ArticleId><ArticleId IdType="pubmed">15884975</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YE, Hayashi YK, Bonne G, Arimura T, Noguchi S, Nonaka I, Nishino I. 2009. Autophagic degradation of nuclear components in mammalian cells. Autophagy 5:795–804. doi:10.4161/auto.8901</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.8901</ArticleId><ArticleId IdType="pubmed">19550147</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y, Shi J, Tang H, Xiang P, Xue YC, Liu H, Ng CS, Luo H. 2020. Coxsackievirus infection induces a non-canonical autophagy independent of the ULK and PI3K complexes. Sci Rep 10:19068. doi:10.1038/s41598-020-76227-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76227-7</ArticleId><ArticleId IdType="pmc">PMC7642411</ArticleId><ArticleId IdType="pubmed">33149253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Sun B, Huang S, Yu D, Zhang X. 2020. Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer. Cell Death Dis 11:579. doi:10.1038/s41419-020-02794-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-02794-2</ArticleId><ArticleId IdType="pmc">PMC7382500</ArticleId><ArticleId IdType="pubmed">32709848</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JW, Kim DG, Park MC, Um JY, Han JM, Park SG, Choi EC, Kim S. 2009. AIMP2 promotes TNFalpha-dependent apoptosis via ubiquitin-mediated degradation of TRAF2. J Cell Sci 122:2710–2715. doi:10.1242/jcs.049767</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.049767</ArticleId><ArticleId IdType="pubmed">19584093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Lenardo MJ, Baltimore D. 2017. 30 years of NF-kB: a blossoming of relevance to human pathobiology. Cell 168:37–57. doi:10.1016/j.cell.2016.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5268070</ArticleId><ArticleId IdType="pubmed">28086098</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, Boroomand S, Suarez A, Si X, Rahmani M, McManus B. 2007. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability. Cell Microbiol 9:2358–2371. doi:10.1111/j.1462-5822.2007.00964.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.00964.x</ArticleId><ArticleId IdType="pubmed">17848167</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096–21103. doi:10.1074/jbc.272.34.21096</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.34.21096</ArticleId><ArticleId IdType="pubmed">9261113</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks AM, Wells JA. 2018. Engineering peptide ligase specificity by proteomic identification of ligation sites. Nat Chem Biol 14:50–57. doi:10.1038/nchembio.2521</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2521</ArticleId><ArticleId IdType="pmc">PMC5726896</ArticleId><ArticleId IdType="pubmed">29155430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal P, Lee C. 2021. N-terminomics - its past and recent advancements. J Proteomics 233:104089. doi:10.1016/j.jprot.2020.104089</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2020.104089</ArticleId><ArticleId IdType="pubmed">33359939</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan JP, Zhao W, Wang HT, Wu KY, Li T, Guo XK, Tong SQ. 2003. Coxsackievirus B3-induced apoptosis and caspase-3. Cell Res 13:203–209. doi:10.1038/sj.cr.7290165</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7290165</ArticleId><ArticleId IdType="pubmed">12862321</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolskaya EA, Romanova LI, Kolesnikova MS, Ivannikova TA, Smirnova EA, Raikhlin NT, Agol VI. 1995. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol 69:1181–1189. doi:10.1128/JVI.69.2.1181-1189.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.2.1181-1189.1995</ArticleId><ArticleId IdType="pmc">PMC188691</ArticleId><ArticleId IdType="pubmed">7529330</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel B, Autret A, Brisac C, Martin-Latil S, Mousson L, Pelletier I, Estaquier J, Colbere-Garapin F. 2009. Apoptotic signaling cascades operating in poliovirus-infected cells. Front Biosci Volume:2181. doi:10.2741/3370</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3370</ArticleId><ArticleId IdType="pubmed">19273192</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez EL, Lagunoff M. 2015. Viral activation of cellular metabolism. Virology 479–480:609–618. doi:10.1016/j.virol.2015.02.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.038</ArticleId><ArticleId IdType="pmc">PMC4424078</ArticleId><ArticleId IdType="pubmed">25812764</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G. 2010. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci USA 107:17345–17350. doi:10.1073/pnas.1010811107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010811107</ArticleId><ArticleId IdType="pmc">PMC2951450</ArticleId><ArticleId IdType="pubmed">20855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinea R, Carrasco L. 1990. Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J 9:2011–2016. doi:10.1002/j.1460-2075.1990.tb08329.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1990.tb08329.x</ArticleId><ArticleId IdType="pmc">PMC551910</ArticleId><ArticleId IdType="pubmed">2161336</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Liu Y, Lyoo H, van Vliet ALW, Wahedi M, de Bruin JW, Roberts RW, Overduin P, Meijer A, Rossmann MG, Thibaut HJ, van Kuppeveld FJM. 2019. Bypassing pan-enterovirus host factor PLA2G16. Nat Commun 10:3171. doi:10.1038/s41467-019-11256-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J, von Castelmur E, Blomen VA, van den Hengel LG, Brockmann M, Baggen J, Thibaut HJ, Nieuwenhuis J, Janssen H, van Kuppeveld FJM, Perrakis A, Carette JE, Brummelkamp TR. 2017. PLA2G16 represents a switch between entry and clearance of picornaviridae. Nature 541:412–416. doi:10.1038/nature21032</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21032</ArticleId><ArticleId IdType="pubmed">28077878</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina A, Santarelli R, Bloise R, Gonnella R, Granato M, Bei R, Modesti A, Cirone M, Bengtsson L, Angeloni A, Faggioni A. 2013. KSHV ORF67 encoded lytic protein localizes on the nuclear membrane and alters emerin distribution. Virus Res 175:143–150. doi:10.1016/j.virusres.2013.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.04.001</ArticleId><ArticleId IdType="pubmed">23623980</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson SM, Tsueng G, Sin J, Mangale V, Rahawi S, McIntyre LL, Williams W, Kha N, Cruz C, Hancock BM, Nguyen DP, Sayen MR, Hilton BJ, Doran KS, Segall AM, Wolkowicz R, Cornell CT, Whitton JL, Gottlieb RA, Feuer R. 2014. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog 10:e1004045. doi:10.1371/journal.ppat.1004045</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Xiong S. 2023. Exosomes mediate coxsackievirus B3 transmission and expand the viral tropism. PLoS Pathog 19:e1011090. doi:10.1371/journal.ppat.1011090</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011090</ArticleId><ArticleId IdType="pmc">PMC9888687</ArticleId><ArticleId IdType="pubmed">36634130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, He S, Minassian A, Li J, Feng P. 2015. Recent advances on viral manipulation of NF-kB signaling pathway. Curr Opin Virol 15:103–111. doi:10.1016/j.coviro.2015.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2015.08.013</ArticleId><ArticleId IdType="pmc">PMC4688235</ArticleId><ArticleId IdType="pubmed">26385424</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Zeng Q, Wang M, Cheng A, Jia R, Chen S, Zhu D, Liu M, Yang Q, Wu Y, Zhao X, Zhang S, Liu Y, Yu Y, Zhang L, Chen X. 2018. Suppression of NF-kB activity: a viral immune evasion mechanism. Viruses 10:409. doi:10.3390/v10080409</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10080409</ArticleId><ArticleId IdType="pmc">PMC6115930</ArticleId><ArticleId IdType="pubmed">30081579</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Yang XL, Schimmel P. 2010. New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 11:668–674. doi:10.1038/nrm2956</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2956</ArticleId><ArticleId IdType="pmc">PMC3042954</ArticleId><ArticleId IdType="pubmed">20700144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Kang YS, Lee JW, Kim HJ, Ahn YH, Park H, Ko YG, Kim S. 2002. P38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance. Proc Natl Acad Sci USA 99:7912–7916. doi:10.1073/pnas.122110199</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.122110199</ArticleId><ArticleId IdType="pmc">PMC122994</ArticleId><ArticleId IdType="pubmed">12060739</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JW, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S. 2012. Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer. J Mol Cell Biol 4:164–173. doi:10.1093/jmcb/mjs018</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjs018</ArticleId><ArticleId IdType="pubmed">22532625</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JM, Park BJ, Park SG, Oh YS, Choi SJ, Lee SW, Hwang SK, Chang SH, Cho MH, Kim S. 2008. AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53. Proc Natl Acad Sci USA 105:11206–11211. doi:10.1073/pnas.0800297105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0800297105</ArticleId><ArticleId IdType="pmc">PMC2516205</ArticleId><ArticleId IdType="pubmed">18695251</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>